/Companies

Recombine

Acquired

New York, US · Founded 2011 · 3 known investors

Find your way into Recombine

Sign up to see every warm intro you have to Recombine

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Recombine team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Acquired by CooperSurgical (The Cooper Companies) May 2016 · $85M (approximately $85 million) · source ↗

Recombine was a New York-based clinical genetics company offering expanded carrier screening (CarrierMap) and non-invasive prenatal testing (ChromoMap) to assess genetic and chromosomal risks for prospective parents.

Founders & leadership

Recombine was founded in 2011 by Alexander Bisignano.

AB
Alexander BisignanoFounder30 Under 30 2015

Board

MT
Mathias TurckBoard director
SMSantiago Munne
Santiago MunneFounder2011–2016Founder at Overture Life

Investors · 3

Reported raises · per SEC filings

Form D private placements

$4.6M disclosed across 2 rounds · 2014–2015

▶$995KraisedOct 2015 · 10 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander BisignanoExecutive Officer, Director
  • Mathias TurckDirector
  • Santiago MunneDirector
Offering amount
$1M
Amount sold
$995K
First sale
Sep 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.6MraisedFeb 2014 · 13 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mathias TurckDirector
  • Santiago MunneExecutive Officer, Director
Offering amount
$3.6M
Amount sold
$3.6M
First sale
Feb 2014
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Recombine went on to found or lead other companies.

In the news

Frequently asked questions

What does Recombine do?
Recombine was a New York-based clinical genetics company offering expanded carrier screening (CarrierMap) and non-invasive prenatal testing (ChromoMap) to assess genetic and chromosomal risks for prospective parents.
Who founded Recombine?
Recombine was founded by Alexander Bisignano in 2011.
Who are Recombine's investors?
Recombine's investors include FirstMark Capital, Nat Turner, Vast Ventures.
How much funding has Recombine raised?
Recombine has disclosed $4.6M raised across 2 rounds.
Where is Recombine headquartered?
Recombine is headquartered in New York, US.